Tynaxie 3 mg (Tablet)
Unit Price: ৳ 5.02 (3 x 10: ৳ 150.60)
Strip Price: ৳ 50.20
Medicine Details
| Category | Details |
|---|---|
| Generic | Bromazepam |
| Company | Navana pharmaceuticals ltd |
Indications
- Emotional disturbances
- Acute tension
- Anxiety states
- Difficulties in interpersonal contact
- Agitation
- Insomnia
- Pseudoangina pectoris
- Pericardial anxiety
- Tachycardia
- Emotiogenic hypertension
- Dyspnea
- Hyperventilation
- Disturbances in the gastrointestinal tract
- Irritable bowel syndrome
- Epigastric pain
- Spasm
- Diarrhea
- Disturbances in the urinary tract
- Frequency
- Irritable bladder
- Dysmenorrhea
- Psychosomatic disorder
- Psychogenic headache
- Asthma
- Gastric ulcer
- Duodenal ulcer
- Emotional reactions to chronic organic disease
Pharmacology
- Powerful psychotropic agent
- Selective reduction of tension and anxiety
- Sedative properties
- Muscle-relaxant properties
- Binds to GABA-A receptor
- Produces conformational change
- Potentiates inhibitory effects
- No influence on other neurotransmitters
Dosage
- Standard outpatient therapy dosage: 1.5-3 mg up to three times daily
- Severe cases dosage: 6-12 mg 2 or 3 times daily
- Treatment duration not more than 8-12 weeks
- Lower doses for elderly and debilitated patients
- Adjusted dosage for children based on bodyweight
Administration
Oral administration
Interaction
- Enhanced sedative effects when combined with other centrally active drugs
- Avoid concomitant intake with alcohol
- Cimetidine may prolong elimination half-life
Contraindications
- Known hypersensitivity to bromazepam
- Severe respiratory insufficiency
- Severe hepatic insufficiency
- Sleep apnea syndrome
Side Effects
- Fatigue
- Drowsiness
- Muscle weakness
- Reduced alertness
- Confusion
- Headache
- Ataxia
- Anterograde amnesia
- Initial occurrence with therapy start
- Disappear with prolonged administration
Pregnancy & Lactation
Safety not established during pregnancy, excreted in breast milk
Precautions & Warnings
- Development of physical and psychological dependence
- Greater dependence in predisposed patients with alcohol history
- Withdrawal symptoms upon treatment termination
- Recommended gradual dosage decrease for termination
- Not recommended for primary treatment of sleeplessness caused by psychotic illness
- Caution while driving or using machineries
Therapeutic Class
Benzodiazepine sedatives
Storage Conditions
Keep in dry place away from light and heat. Keep out of reach of children